In this animation,I will be show you human trial on COVID19 vaccine
Oxford has initiated human trials for the first COVID-19 vaccine in Europe, according to the BBC.
Citing the university, BBC reports on April 23 that the experimental COVID-19 vaccine takes the coronavirus’s genetic material and inserts the substance into adenoviruses that are responsible for the common cold.
The cold viruses are weakened so that they cannot grow inside the human body after injection.
The modified viruses should make the human cells produce the same spike proteins that study the surface of the coronaviruses and teach the immune system to recognize COVID-19. When vaccine recipients actually encounter the coronavirus, their bodies’ immune system would then be able to identify the treat and scramble antibodies and natural killer T cells to fight off the infection.
At the time of report, two volunteers have received the shot, out of around 800 recruited for the first phase human trial. Citing the doctors, the BBC reports potential side effects include headache, fever and muscle pains a couple of days after the injection.
#MohdAsifBiotech
#MohdAsif
#Humantrial
You can follow us on following social site
Disclaimer –
this video is for educational purpose only.Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing.
Non-profit, educational or personal use tips the balance in favor of fair use.
